Clinical Trial

Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Completed
View on ClinicalTrials.gov →
Summary
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Protocol Amendment History 1 change
critical Trial completed 2026-07-10
Trial Details
NCT Number NCT07619495
Lead Sponsor Brigham and Women's Hospital
Conditions Type 2 Diabetes Mellitus, Obesity, Overweight
Enrollment 120,000 participants
Start Date 2026-01-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-09